As of May 22
| -0.071 / -1.17%|
The 3 analysts offering 12-month price forecasts for Starpharma Holdings Ltd have a median target of 8.70, with a high estimate of 8.83 and a low estimate of 7.81. The median estimate represents a +44.95% increase from the last price of 6.00.
The current consensus among 3 polled investment analysts is to Buy stock in Starpharma Holdings Ltd. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.